Entrada Therapeutics Inc (TRDA)
15.10
+0.15
(+1.00%)
USD |
NASDAQ |
May 20, 11:13
Entrada Therapeutics Market Cap: 509.76M for May 20, 2024
Market Cap Chart
Historical Market Cap Data
| Date | Value |
|---|---|
| May 17, 2024 | 506.05M |
| May 16, 2024 | 504.70M |
| May 15, 2024 | 489.17M |
| May 14, 2024 | 479.04M |
| May 13, 2024 | 474.31M |
| May 10, 2024 | 484.10M |
| May 09, 2024 | 484.78M |
| May 08, 2024 | 474.31M |
| May 07, 2024 | 468.57M |
| May 06, 2024 | 455.75M |
| May 03, 2024 | 444.27M |
| May 02, 2024 | 457.77M |
| May 01, 2024 | 447.31M |
| April 30, 2024 | 400.04M |
| April 29, 2024 | 415.59M |
| April 26, 2024 | 419.29M |
| April 25, 2024 | 416.26M |
| April 24, 2024 | 418.62M |
| April 23, 2024 | 434.11M |
| April 22, 2024 | 441.18M |
| April 19, 2024 | 409.19M |
| April 18, 2024 | 401.10M |
| April 17, 2024 | 411.54M |
| April 16, 2024 | 428.38M |
| April 15, 2024 | 433.16M |
| Date | Value |
|---|---|
| April 12, 2024 | 435.17M |
| April 11, 2024 | 445.59M |
| April 10, 2024 | 420.72M |
| April 09, 2024 | 446.26M |
| April 08, 2024 | 451.98M |
| April 05, 2024 | 464.07M |
| April 04, 2024 | 464.74M |
| April 03, 2024 | 464.07M |
| April 02, 2024 | 466.42M |
| April 01, 2024 | 462.39M |
| March 28, 2024 | 476.13M |
| March 27, 2024 | 482.18M |
| March 26, 2024 | 462.35M |
| March 25, 2024 | 449.58M |
| March 22, 2024 | 461.01M |
| March 21, 2024 | 454.96M |
| March 20, 2024 | 448.57M |
| March 19, 2024 | 426.73M |
| March 18, 2024 | 416.99M |
| March 15, 2024 | 429.42M |
| March 14, 2024 | 409.93M |
| March 13, 2024 | 427.07M |
| March 12, 2024 | 389.10M |
| March 11, 2024 | 395.15M |
| March 08, 2024 | 426.06M |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
172.20M
Minimum
May 09 2022
1.094B
Maximum
Nov 17 2021
456.64M
Average
458.80M
Median
Market Cap Benchmarks
| Catalyst Pharmaceuticals Inc | 1.957B |
| Vertex Pharmaceuticals Inc | 115.31B |
| Sarepta Therapeutics Inc | 12.17B |
| PTC Therapeutics Inc | 2.986B |
| GlycoMimetics Inc | 18.22M |
Market Cap Related Metrics
| PE Ratio | 23.97 |
| PS Ratio | 3.154 |
| Price to Book Value | 1.892 |
| Price | 15.10 |
| Earnings Yield | 4.17% |
| Operating PE Ratio | 21.65 |
| Normalized PE Ratio | 23.97 |